In the vaccines segment, GSK maintained its leadership in the self-pay private market for Paediatric vaccines, the company ...

India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin. The Indian unit of ...

GSK Pharma reported strong Q3 performance with revenue up 18% and EBITDA rising 34%. Key brands, including Augmentin and ...

Augmentin tablets. WHO has issued an alert that ... to be a close imitation of the genuine product manufactured by GSK (GlaxoSmithKline),” WHO said in a statement. WHO says it has informed ...

Four of the top 5 selling products of GSK are antibiotics (Augmentin, Duricef, Ceporex and Velosef). Two of them come from BMS. By having four well established - and relatively old - antibiotic ...

Abbott India posts Q2 profit rise on strong demand, price hikes November 7, 2024 India's GlaxoSmithKline Pharmaceuticals reported a higher second-quarter adjusted profit on Tuesday, driven by ...